Cerebellar Cognitive Affective Syndrome Improved by Donepezil

Intern Med. 2019 Apr 1;58(7):1003-1006. doi: 10.2169/internalmedicine.1206-18. Epub 2018 Dec 18.

Abstract

Cerebellar damage can cause not only disturbance in motor control but also higher brain dysfunction known as cerebellar cognitive affective syndrome (CCAS). Although CCAS has a high prevalence, the precise mechanism and effective medications are unknown. We herein report a CCAS patient whose symptoms were ameliorated with the cholinesterase inhibitor donepezil. N-isopropyl-p-123I-iodoamphetamine-single-photon emission computed tomography showed improvement in hypoperfusion in the contralateral frontal and parieto-temporal lobes. Some projections with cholinergic transmission might form a functional connectivity between the cerebellum and contralateral association cortices, and cholinergic dysfunction is involved in CCAS pathophysiology. Donepezil might be worth considering for some CCAS patients.

Keywords: SPECT; cerebellar cognitive affective syndrome; cerebral blood flow; cholinesterase inhibitors; crossed hemispheric diaschisis; donepezil.

Publication types

  • Case Reports

MeSH terms

  • Cerebellar Diseases / diagnosis
  • Cerebellar Diseases / drug therapy*
  • Cerebellar Diseases / physiopathology
  • Cerebellum / blood supply
  • Cerebellum / diagnostic imaging*
  • Cerebrovascular Circulation / physiology*
  • Cholinesterase Inhibitors / therapeutic use
  • Cognition / physiology*
  • Donepezil / therapeutic use*
  • Humans
  • Male
  • Middle Aged
  • Tomography, Emission-Computed, Single-Photon

Substances

  • Cholinesterase Inhibitors
  • Donepezil